Loading provider…
Loading provider…
Gynecologic Oncology Physician in Chapel Hill, NC
NPI: 1073601365Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get MD Linda's Phone NumberMobile
Get MD Linda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License

American Board of Obstetrics and Gynecology
Gynecologic Oncology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 63 | 90 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 30 | 53 |
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
Authors: Siobhan Kehoe, Heidi Gray, Carol Aghajanian, Michael Carney, Michael Pearl, Lisa Landrum
Publication Date: 2017-12-16
Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.
Authors: Victoria Bae-Jump, John Boggess, Jessica Stine, John Soper, Kemi Doll, Kenneth Kim
Journal: Gynecol Oncol
Publication Date: 2013-03-29
Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation Toxicity.
Authors: Van Le, Linda, McCormack, Mary
Journal: Am Soc Clin Oncol Educ Book
Lead Sponsor: University of Oklahoma
Collaborators: Tesaro, Inc.
Intervention / Treatment: DRUG: Niraparib, DRUG: dostarlimab
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Collaborators: Genmab
Intervention / Treatment: DRUG: irinotecan, DRUG: tisotumab vedotin, DRUG: gemcitabine, DRUG: pemetrexed, DRUG: topotecan, DRUG: vinorelbine
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, RADIATION: External Beam Radiation Therapy, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, RADIATION: Brachytherapy